Monday, April 20, 2026

The Omnichannel Gap: Building the CRM of the Future for Patient Services

Today’s guest post comes from Karishma Desai, Associate Director of Data Strategy at Claritas Rx.

Karishma explains how the complexities of specialty therapies require a customer relationship management (CRM) system that unifies consent management. She goes on to explain that by embedding AI into the patient journey, automating workflows at scale, and enhancing collaboration among stakeholders, organizations can reduce delays, improve adherence, and deliver better patient outcomes.

To learn more, download Claritas Rx’s white paper: The Omnichannel Gap: Building the CRM of the Future for Patient Services.

Read on for Karishma's insights.

The Omnichannel Gap: Building the CRM of the Future for Patient Services
By Karishma Desai, Associate Director of Data Strategy, Claritas Rx

Specialty and rare disease therapies have never been more complex. Patients move through a maze of benefit pathways, distribution models, and touchpoints across hubs, specialty pharmacies, providers, and manufacturers. Yet the systems meant to support these journeys are still largely built around channels, not patients.

Download the white paper to see how leading teams are closing this gap.

The result is an omnichannel gap: traditional CRMs can push messages, but they can’t consistently orchestrate the right action at the right moment across every stakeholder. Most patient services teams feel this gap every day. Matrix meetings, manual triage, spreadsheets, and phone calls are still doing too much of the work that should be handled by integrated systems.

Of patients who go 7 to 180 days post-referral without a shipment, 1 in 5 will never receive one. Every day of delay increases the likelihood they will never start therapy.

Two Engagement Models. One Overlooked Distinction.

CRMs often function as broadcast tools rather than a true system of record and action. They rarely distinguish between two fundamentally different engagement models:

  • Direct manufacturer-to-patient support, which depends on explicit consent

  • Collaborative partner engagement, which depends on coordinated data sharing across hubs, SPs, and providers

Treating these models as if they’re the same introduces operational risk, compliance friction, and inconsistent patient experiences.

Consent as a Strategic Asset, Not a Checkbox

Consent sits at the center of this problem—and the solution. In many programs, consent is captured late, stored in silos, or tied to a single workflow or channel. That limits visibility and constrains engagement. Teams are left asking basic questions they should be able to answer instantly: Who can we reach? Through which channels? For what services? Instead of acting as a strategic asset, consent becomes a constraint.

"Unified consent management can drive 12–40% higher cohort fill rates and an 11% increase in patient persistence on therapy."

The path forward is to treat consent as a dynamic, unified data layer that governs access, communication, and workflows across the entire ecosystem. When consent is embedded into the core CRM architecture, instead of bolted on at the margins, it unlocks a very different operating model. For consented patients, it enables personalized, HIPAA-compliant omnichannel engagement. For all patients, it supports compliant journey visibility so hubs, specialty pharmacies, and field teams can monitor progress and coordinate action without overstepping data boundaries.

The Five Pillars of Total Patient Management

This is the foundation of a total patient management system—something more than a CRM with extra channels. It rests on five interconnected pillars:

1) Unified Patient Intelligence
A single source of truth combining longitudinal history, real-time tracking, and visibility into bottlenecks, delays, and discontinuations across the patient journey. Consent governs activation—enabling personalized, compliant omnichannel engagement for consented patients, while providing compliant visibility for all others so teams can coordinate and ensure no patient falls through the cracks.

2) AI-Driven Orchestration
Predictive models and next-best-action engines embedded directly into workflows—shifting from reactive case handling to proactive, intelligence-driven interventions. Risk prediction models catch up to 30% more cases, improving efficiency and intervention success rates while getting smarter over time.

3) Workflow Automation at Scale
Integrated task queues, automated routing, and real-time updates eliminate manual inefficiencies. By embedding omnichannel tools, like SMS, e-fax, and patient portals, directly into the workflow, teams are free to focus on what matters most: the patient.

4) Analytics Tied to Outcomes
Role-based dashboards surfacing journey-level performance, access bottlenecks, time-to-fill, abandonment risk, and intervention impact—not just activity metrics.

5) Real-Time Collaboration
When hubs, SPs, field teams, and patient services all see the same truth—appropriate to their roles—they can coordinate around the patient rather than the process.

Intelligence Into Action: Key Risk Drivers
When these pillars come together, teams can operationalize four key risk drivers into concrete triggers and actions:
  • Access—PA aging prompts escalations and bridge shipments
  • Affordability—Copay risk triggers financial assistance workflows
  • Engagement—Gaps in contact drive immediate outreach
  • Clinical—Dosage changes initiate prescriber check-ins

For every five additional days it takes to fill a prescription, fill rates fall by 30%. A unified, intelligence-driven CRM foundation enables teams to intervene early, before delays cause patients to abandon starting therapy.

The Bottom Line

The next generation of patient services CRM cannot be another channel-centric tool. It must be a total patient management system that unifies consent-managed data, embeds AI into everyday work, and orchestrates proactive, cross-stakeholder action.

Organizations that make this shift will reduce time-to-therapy, improve fill and persistence, and lighten the operational load on their teams—while delivering a more connected, human experience for every patient.

Download the White Paper
Explore how leading teams are closing the Omnichannel Gap.


Sponsored guest posts are bylined articles that are screened by Drug Channels to ensure a topical relevance to our exclusive audience. The content of Sponsored Posts does not necessarily reflect the views of HMP Omnimedia, LLC, Drug Channels Institute, its parent company, or any of its employees. To find out how you can publish a guest post on Drug Channels, please contact Paula Fein (paula@DrugChannels.net).

No comments:

Post a Comment